Publicacions
-
Morón S, Blasco-Roset A, Navarro-Gascon A, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Uriarte I, Fernández-Barrena MG, Avila M, Ferrer-Curriu G, Lupón J, Bayés-Genis A, Villarroya-Gombau F, Gavaldà-Navarro A and Planavila A.
A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy.
JOURNAL OF PATHOLOGY . 261(3): 335-348. Nº de cites: 2
-
Rupérez CH, Ferrer-Curriu G, Cervera-Barea A, Florit L, Guitart-Mampel M, Garrabou G, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Fernandez-Solà J, Lupón J, Bayes-Genis A, Villarroya-Gombau F and Planavila A.
Meteorin-like/Meteorin-ß protects heart against cardiac dysfunction.
JOURNAL OF EXPERIMENTAL MEDICINE . 218(5): 20201206. Nº de cites: 40
-
Ferrer-Curriu G, Guitart-Mampel M, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Villarroya-Gombau F, Fernández-Solà J, Garrabou G and Planavila A.
The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
JOURNAL OF PATHOLOGY . 253(2): 198-208. Nº de cites: 23
-
Rupérez CH, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya-Terrade J, Giralt M, Villarroya-Gombau F and Planavila A.
Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy
INTERNATIONAL JOURNAL OF CARDIOLOGY . 260: 163-170. Nº de cites: 34